The stock price of Neuronetics Inc (NASDAQ: STIM) has jumped by 0.30 compared to previous close of 4.94. Despite this, the company has seen a gain of 7.02% in its stock price over the last five trading days. zacks.com reported 2025-03-18 that The mean of analysts’ price targets for Neuronetics (STIM) points to a 35% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Is It Worth Investing in Neuronetics Inc (NASDAQ: STIM) Right Now?
The stock has a 36-month beta value of 1.82. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for STIM is 8.56M, and at present, short sellers hold a 23.20% of that float. On March 19, 2025, the average trading volume of STIM was 1.51M shares.
STIM’s Market Performance
STIM stock saw a decrease of 7.02% in the past week, with a monthly decline of -0.90% and a quarterly a decrease of 342.41%. The volatility ratio for the week is 10.77%, and the volatility levels for the last 30 days are 13.59% for Neuronetics Inc (STIM). The simple moving average for the last 20 days is 6.52% for STIM’s stock, with a simple moving average of 165.40% for the last 200 days.
STIM Trading at 36.40% from the 50-Day Moving Average
After a stumble in the market that brought STIM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.30% of loss for the given period.
Volatility was left at 13.59%, however, over the last 30 days, the volatility rate increased by 10.77%, as shares surge +11.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +234.23% upper at present.
During the last 5 trading sessions, STIM rose by +7.56%, which changed the moving average for the period of 200-days by +162.11% in comparison to the 20-day moving average, which settled at $4.65. In addition, Neuronetics Inc saw 207.76% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STIM starting from Furlong Stephen, who sale 1,867 shares at the price of $4.48 back on Mar 04 ’25. After this action, Furlong Stephen now owns 610,053 shares of Neuronetics Inc, valued at $8,364 using the latest closing price.
MACAN WILLIAM ANDREW, the EVP, GC, CCO and CS of Neuronetics Inc, sale 377 shares at $4.48 during a trade that took place back on Mar 04 ’25, which means that MACAN WILLIAM ANDREW is holding 526,805 shares at $1,689 based on the most recent closing price.
Stock Fundamentals for STIM
Current profitability levels for the company are sitting at:
- -0.45 for the present operating margin
- 0.72 for the gross margin
The net margin for Neuronetics Inc stands at -0.58. The total capital return value is set at -0.33. Equity return is now at value -138.47, with -34.66 for asset returns.
Based on Neuronetics Inc (STIM), the company’s capital structure generated 0.49 points at debt to capital in total, while cash flow to debt ratio is standing at -0.74. The debt to equity ratio resting at 0.97. The interest coverage ratio of the stock is -4.67.
Currently, EBITDA for the company is -34.04 million with net debt to EBITDA at -0.26. When we switch over and look at the enterprise to sales, we see a ratio of 2.78. The receivables turnover for the company is 3.08for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.85.
Conclusion
To sum up, Neuronetics Inc (STIM) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
